If You Invested in Checkmate Pharmaceuticals, Inc. (CMPI)
Looking for the current price? See the CMPI quote & overviewWhat $1,000 or $10,000 in CMPI Would Be Worth Now
Real historical value by amount invested and how long ago| If you invested | 1 year ago | 5 years ago | 10 years ago | Since Aug 7, 2020 |
|---|---|---|---|---|
| $1,000 | — | $2,542 +154% | — | $750 -25% |
| $10,000 | — | $25,424 +154% | — | $7,500 -25% |
Based on real historical closing prices adjusted for stock splits, without dividends, through 2022-05-27. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for CMPI$1,000 Investment Over Time
CMPI vs S&P 500Year-by-Year Returns
CMPI annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2020 | $14.00 | $14.59 | +4.2% | +4.2% |
| 2021 | $14.59 | $2.87 | -80.3% | -79.5% |
| 2022 | $2.87 | $10.50 | +265.9% | -25.0% |
About Checkmate Pharmaceuticals, Inc.
Healthcare · NASDAQ
Similar Stocks
See how related companies performed
Frequently Asked Questions
Checkmate Pharmaceuticals, Inc. investment returns
How much would $1,000 invested in Checkmate Pharmaceuticals, Inc. be worth today?
If you invested $1,000 in Checkmate Pharmaceuticals, Inc. (CMPI) 5 years ago on 2021-10-22, your investment would be worth $2,542 as of 2022-05-27, a +154.2% price return without dividends, growing at a compounded rate of 380.9% per year (CAGR).
Has Checkmate Pharmaceuticals, Inc. outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare CMPI performance over available time periods.
What is Checkmate Pharmaceuticals, Inc.'s average annual return?
The compound annual growth rate (CAGR) of CMPI’s share price over the past 5 years is 380.9%, without dividends. Individual years vary a great deal, and CMPI’s best recent full year was 2021 (-80.3%) while the worst was 2021 (-80.3%).
For informational and educational purposes only, not investment advice.
